These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24641586)
1. Vitamin D resistance in chronic kidney disease (CKD). Parikh A; Chase HS; Vernocchi L; Stern L BMC Nephrol; 2014 Mar; 15():47. PubMed ID: 24641586 [TBL] [Abstract][Full Text] [Related]
2. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial. Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985 [TBL] [Abstract][Full Text] [Related]
4. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease. Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999 [TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Wetmore JB; Kimber C; Mahnken JD; Stubbs JR Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Jean G; Souberbielle JC; Chazot C Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria. Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D in chronic kidney disease. Chau YY; Kumar J Indian J Pediatr; 2012 Aug; 79(8):1062-8. PubMed ID: 22544696 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D. Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Moe SM; Saifullah A; LaClair RE; Usman SA; Yu Z Clin J Am Soc Nephrol; 2010 Feb; 5(2):299-306. PubMed ID: 20056760 [TBL] [Abstract][Full Text] [Related]
11. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. Ennis JL; Worcester EM; Coe FL; Sprague SM J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. Kim SM; Choi HJ; Lee JP; Kim DK; Oh YK; Kim YS; Lim CS J Ren Nutr; 2014 Jan; 24(1):20-5. PubMed ID: 24216258 [TBL] [Abstract][Full Text] [Related]
13. [Cholecalciferol supplementation improves secondary hyperparathyroidism control in renal transplant recipient]. Massimetti C; Imperato G; Feriozzi S G Ital Nefrol; 2020 Aug; 37(4):. PubMed ID: 32809289 [No Abstract] [Full Text] [Related]
14. Vitamin D levels, vitamin D supplementation, and prognosis in patients with chronic kidney disease . Namir Y; Cohen MJ; Haviv YS; Slotki I; Shavit L Clin Nephrol; 2016 Oct; 86(10):165-74. PubMed ID: 27616756 [TBL] [Abstract][Full Text] [Related]
15. Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Kovesdy CP; Lu JL; Malakauskas SM; Andress DL; Kalantar-Zadeh K; Ahmadzadeh S Am J Kidney Dis; 2012 Jan; 59(1):58-66. PubMed ID: 21885174 [TBL] [Abstract][Full Text] [Related]
16. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Zisman AL; Hristova M; Ho LT; Sprague SM Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573 [TBL] [Abstract][Full Text] [Related]
17. Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease. Agarwal R; Georgianos PI Nephrol Dial Transplant; 2016 May; 31(5):706-13. PubMed ID: 27190392 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Hari P; Gupta N; Hari S; Gulati A; Mahajan P; Bagga A Pediatr Nephrol; 2010 Dec; 25(12):2483-8. PubMed ID: 20872152 [TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy. Alshayeb HM; Wall BM; Showkat A; Quarles LD; Mangold T Am J Med Sci; 2013 Apr; 345(4):314-320. PubMed ID: 23221508 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]